GRAIL Q2 revenue $35.5M (+11% YoY); net loss $114M includes $28M impairment

GRAIL, Inc.

2025-Q2 EPS reported -$6.28 revenue$67,381,000

U.S. Galleri revenue $34.2M (+21% YoY); Galleri tests sold >45,000 (+29% YoY).
Non-GAAP adjusted EBITDA $(78.3)M, improving 44% YoY from $(139.4)M.
Cash and marketable securities $606.1M as of June 30, 2025.
PATHFINDER 2 detailed results to be submitted for presentation at ESMO 2025 in October.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.